|
VRX496 Update, Novel HIV Gene Therapy
|
|
|
VIRxSYS Announces Completion of Phase I Study of VRX496, Novel HIV ...
The viral vector plus antisense is called VRX496. The antisense genetic medicine blocks HIV replication in CD4 T cells, which would otherwise be destroyed ...
www.natap.org/2005/newsUpdates/050505-01.htm -
HIV gene therapy study 'shows promise'
The researchers are now recruiting for a second trial of the treatment - dubbed VRX496. This time it will be tested on patients whose HIV load is already ...
www.natap.org/2006/newsUpdates/110906_03.htm
![con-1.gif](../images/012709/con-1.gif)
![gern2.gif](../images/012709/gern2.gif)
![cell-3.gif](../images/012709/cell-3.gif)
![Vector-4.gif](../images/012709/Vector-4.gif)
![Vector5.gif](../images/012709/Vector5.gif)
![summy6.gif](../images/012709/summy6.gif)
![phase7.gif](../images/012709/phase7.gif)
![PHase8.gif](../images/012709/PHase8.gif)
![amont9.gif](../images/012709/amont9.gif)
![Anal10.gif](../images/012709/Anal10.gif)
![figure11.gif](../images/012709/figure11.gif)
![lab12.gif](../images/012709/lab12.gif)
![Journ13.gif](../images/012709/Journ13.gif)
![Anit14.gif](../images/012709/Anit14.gif)
![delete15.gif](../images/012709/delete15.gif)
![AG-16.gif](../images/012709/AG-16.gif)
![HIgh-17.gif](../images/012709/HIgh-17.gif)
![And-18.gif](../images/012709/And-18.gif)
|
|
|
|
|
|
|